Related Experiment Video
Updated: Nov 9, 2025

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
Published on: November 2, 2017
Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis
Dongxue Su1,2, Wenjuan Wang1, Yongqiang Hou2,3
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Abstract:
Although overexpression of EZH2, a catalytic subunit of the polycomb repressive complex 2 (PRC2), is an eminent feature of various cancers, the regulation of its abundance and function remains insufficiently understood. We report here that the PRC2 complex is physically associated with ubiquitin-specific protease USP7 in cancer cells where USP7 acts to deubiquitinate and stabilize EZH2. Interestingly, we found that USP7-catalyzed H2BK120ub1 deubiquitination is a prerequisite for chromatin loading of PRC2 thus H3K27 trimethylation, and this process is not affected by H2AK119 ubiquitination catalyzed by PRC1. Genome-wide analysis of the transcriptional targets of the USP7/PRC2 complex identified a cohort of genes including FOXO1 that are involved in cell growth and proliferation. We demonstrated that the USP7/PRC2 complex drives cancer cell proliferation and tumorigenesis in vitro and in vivo. We showed that the expression of both USP7 and EZH2 elevates during tumor progression, corresponding to a diminished FOXO1 expression, and the level of the expression of USP7 and EZH2 strongly correlates with histological grades and prognosis of tumor patients. These results reveal a dual role for USP7 in the regulation of the abundance and function of EZH2, supporting the pursuit of USP7 as a therapeutic target for cancer intervention.
Insights
Ubiquitin-specific protease 7 (USP7) stabilizes EZH2, a key cancer protein, by deubiquitination. This USP7/EZH2 complex drives cancer growth and progression, highlighting USP7 as a potential therapeutic target.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- Overexpression of EZH2 (Enhancer of Zeste Homolog 2), a subunit of Polycomb Repressive Complex 2 (PRC2), is common in various cancers.
- The precise regulation of EZH2 abundance and function in cancer remains unclear.
Purpose of the Study:
- To investigate the regulatory relationship between USP7 (Ubiquitin-Specific Protease 7) and EZH2 in cancer cells.
- To elucidate the role of USP7 in EZH2 stability, PRC2 activity, and cancer progression.
Main Methods:
- Co-immunoprecipitation to confirm physical association between USP7 and PRC2/EZH2.
- Western blotting to assess protein levels and ubiquitination status (H2BK120ub1, H2AK119ub1).
- Genome-wide analysis to identify transcriptional targets of the USP7/PRC2 complex.
- In vitro and in vivo assays to evaluate the impact on cancer cell proliferation and tumorigenesis.
Main Results:
- USP7 physically associates with PRC2 and deubiquitinates EZH2, thereby stabilizing it.
- USP7-mediated H2BK120ub1 deubiquitination is essential for PRC2 chromatin loading and H3K27 trimethylation.
- The USP7/PRC2 complex targets genes involved in cell growth, such as FOXO1, promoting cancer proliferation and tumorigenesis.
- Elevated USP7 and EZH2 expression correlates with tumor progression, reduced FOXO1 levels, higher histological grades, and poorer patient prognosis.
Conclusions:
- USP7 plays a dual role in regulating EZH2 abundance and function, critical for cancer cell proliferation.
- The USP7/EZH2 axis represents a promising therapeutic target for cancer intervention.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Nuclear Protein Sorting

